United States Mammography Equipment Market Outlook to 2033: Full Field Digital Mammography Equipment

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$4995

GlobalData’s “United States Mammography Equipment Market Outlook to 2033” is a comprehensive databook report, covering key market data on the United States Mammography Equipment market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Full Field Digital Mammography Equipment

The United States Mammography Equipment Market report provides key information and data on –
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
• 2023 company share data for Mammography Equipment Market.
• Global corporate-level profiles of key companies operating within the United States Mammography Equipment Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United States Mammography Equipment is segmented as follows – _x000D_

• Full Field Digital Mammography Equipment

Reasons to Buy

The United States Mammography Equipment Market report helps you to develop –

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Hologic Inc_x000D_
Siemens Healthineers AG_x000D_
GE HealthCare Technologies Inc_x000D_
Fujifilm Holdings Corp

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 5

2 Introduction 6

2.1 What Is This Report About? 6

2.2 Mammography Equipment Market Segmentation 6

2.3 Definitions of Markets Covered in the Report 7

3 Mammography Equipment Market, United States 8

3.1 Mammography Equipment Market, United States, Revenue ($m), 2018-2033 8

3.1.1 Full Field Digital Mammography Equipment Market, United States, Revenue ($m), by Segment, 2018-2033 10

3.2 Mammography Equipment Market, United States, Volume (Units), 2018-2033 12

3.2.1 Full Field Digital Mammography Equipment Market, United States, Volume (Units), by Segment, 2018-2033 14

3.3 Mammography Equipment Market, United States, Average Price ($), 2018-2033 16

3.4 Mammography Equipment Market, United States, Company Share by Revenue ($m), 2024 17

4 Overview of Key Companies in United States, Mammography Equipment Market 18

4.1 Hologic Inc 18

4.1.1 Company Overview 18

4.2 Siemens Healthineers AG 18

4.2.1 Company Overview 18

4.3 GE HealthCare Technologies Inc 18

4.3.1 Company Overview 18

4.4 Fujifilm Holdings Corp 19

4.4.1 Company Overview 19

5 Mammography Equipment Market Pipeline Products 20

6 Financial Deals Landscape 21

6.1 Debt Offerings 21

6.1.1 GE HealthCare Technologies Raises USD1 Billion in Public Offering of

4.800% Senior Notes Due 2029 21

6.2 Equity Offerings 23

6.2.1 GE HealthCare Technologies to Raise Funds in Secondary Offering of Shares 23

6.2.2 GE HealthCare Technologies Prices to Raise USD1.29 Billion in Upsized Secondary Offering of Shares 24

7 Recent Developments 25

7.1 Corporate Communications 25

7.1.1 Dec 09, 2024: Hologic Appoints Dr. Martin Madaus to Its Board 25

7.1.2 Sep 11, 2024: Solis Mammography Earns Great Place to Work Certification for Third Year in a Row 25

7.2 Financial Announcements 25

7.2.1 Jul 02, 2025: Hologic to Announce Financial Results for the Third Quarter of Fiscal 2025 on Wednesday, July 30, 2025 25

7.2.2 Apr 17, 2025: GE HealthCare to Announce First Quarter 2025 Results on April 30, 2025 26

7.2.3 Apr 03, 2025: Revvity to Hold Earnings Call on Monday, April 28, 2025 26

7.2.4 Mar 19, 2025: iCAD Posts Results for Q4 and Fiscal Year Ended December 31, 2024 26

7.2.5 Feb 05, 2025: Hologic Reports Results for Q1 of Fiscal 2025 27

7.2.6 Jan 31, 2025: Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2024 28

7.2.7 Jan 12, 2025: Revvity to Hold Earnings Call on Friday, January 31, 2025; Provides Update on Financial Performance 29

7.2.8 Jan 06, 2025: Hologic to Announce Financial Results for the First Quarter of Fiscal 2025 on Wednesday, February 5, 2025 29

7.2.9 Dec 12, 2024: GE HealthCare to Announce Fourth Quarter and Full Year 2024 Results on February 13, 2025 29

7.2.10 Nov 12, 2024: Oxford Instruments Announces Half-Year Results 29

7.2.11 Nov 04, 2024: Revvity Announces Financial Results for the Third Quarter of 2024 30

7.2.12 Oct 07, 2024: Revvity to Hold Earnings Call on Monday, November 4, 2024 31

7.2.13 Oct 04, 2024: Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2024 on Monday, November 4, 2024 31

7.3 Government and Public Interest 32

7.3.1 Jul 10, 2025: Study: Quick, Pain-Free Breast Imaging System Shows Promise in Early Clinical Tests 32

7.3.2 Mar 27, 2025: Vanqua Bio to Present at the AD/PD 2025 International Conference 33

7.3.3 Mar 17, 2025: Enveric Biosciences Participating in BIO-Europe Spring 33

7.3.4 Feb 10, 2025: GE Healthcare Management to Present at Upcoming Investor Conference 34

7.3.5 Nov 19, 2024: Revvity to Present at 7th Annual Evercore ISI HealthCONx Conference 34

7.3.6 Oct 09, 2024: Livzon Pharmaceutical Group Announcement on the Approval for the New Indication of Triptorelin Acetate Microspheres for Injection 34

7.3.7 Oct 03, 2024: Aldeyra Therapeutics Resubmits Reproxalap New Drug Application for the Treatment of Dry Eye Disease 36

7.3.8 Aug 12, 2024: FDA approves IASO Bio’s IND for equecabtagene autoleucel 36

7.4 Legal And Regulatory 37

7.4.1 Jan 08, 2025: Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE (amifampridine) Patent Litigation with Teva Pharmaceuticals 37

7.5 Other Significant Developments 38

7.5.1 Oct 07, 2024: WakeMed and Siemens Healthineers Bring Vital Mammography Screenings to the Community During Breast Cancer Awareness Month 38

7.5.2 Oct 01, 2024: Am I Too Young for a Mammogram 38

7.5.3 Sep 10, 2024: New Breast Density Reporting Requirement Empowers Women with Vital Information; Susan G. Komen(R) Urges Access to Affordable Care 39

7.6 Product News 40

7.6.1 Jul 15, 2025: RSNA: AI Tool Accurately Detects Tumor Location on Breast MRI 40

7.6.2 Feb 26, 2025: DeepHealth Introduces New AI-Powered Radiology Informatics and Population Screening Solutions at ECR2025 41

7.6.3 Oct 08, 2024: Tra Medical Imaging Foundation Brings Mobilemammo NW to the South Sound 42

7.6.4 Oct 01, 2024: Mayo Clinic Health System Discusses Advancements in Breast Cancer Screenings 42

7.6.5 Sep 17, 2024: Advanced 3D Mammography Detects More Breast Cancers, Fewer False Positives 43

7.6.6 Aug 16, 2024: Safe Seated Mammography Using Enable Me's VELA Mammography Chair Can Improve Image Clarity this World Breast Cancer Research Day Aug. 18 43

7.7 Strategy And Business Planning 44

7.7.1 Jul 10, 2025: Shionogi Announces Implementation of Stibo Systems MDM Solution 44

7.7.2 May 12, 2025: Fujifilm Strengthens Partnership With the National Rural Health Association To Improve Access to Medical Imaging in Rural Communities 44

7.7.3 Oct 10, 2024: US Radiology Specialists Launches Next Phase of its Technologist Advancement Academy With Expansion Into Mammography 45

8 Appendix 46

8.1 Research Methodology 47

8.1.1 Coverage 47

8.1.2 Secondary Research 47

8.1.3 Primary Research 47

8.1.4 Market Modeling and Forecasting 48

8.1.5 Company Share Analysis 49

8.1.6 Benchmarking 50

8.2 GlobalData Consulting 50

8.3 Contact Us 50

8.4 Disclaimer 51

Table

Table 1: Mammography Equipment Market, United States, Revenue ($m), USD Constant, 2018-2033 9

Table 2: Full Field Digital Mammography Equipment Market, United States, Revenue ($m), USD Constant, 2018-2033 11

Table 3: Mammography Equipment Market, United States, Volume (Units), 2018-2033 13

Table 4: Full Field Digital Mammography Equipment Market, United States, Volume (Units), 2018-2033 15

Table 5: Mammography Equipment Market, United States, Average Price ($), 2018-2033 16

Table 6: Mammography Equipment Market, United States, Company Share by Revenue ($m), 2024 17

Table 7: Mammography Equipment Market Pipeline Products 20

Table 8: GE HealthCare Technologies Raises USD1 Billion in Public Offering of 4.800% Senior Notes Due 2029 21

Table 9: GE HealthCare Technologies to Raise Funds in Secondary Offering of Shares 23

Table 10: GE HealthCare Technologies Prices to Raise USD1.29 Billion in Upsized Secondary Offering of Shares 24

Table 11: Total Number of Primary Research Participants, Diagnostic Imaging Market, by Country 48

Figures

Figure 1: Mammography Equipment Market, United States, Revenue ($m), USD Constant, 2018-2033 8

Figure 2: Full Field Digital Mammography Equipment Market, United States, Revenue ($m), USD Constant, 2018-2033 10

Figure 3: Mammography Equipment Market, United States, Volume (Units), 2018-2033 12

Figure 4: Full Field Digital Mammography Equipment Market, United States, Volume (Units), 2018-2033 14

Figure 5: Mammography Equipment Market, United States, Company Share (%), 2024 17

United States Mammography Equipment Market Outlook to 2033: Full Field Digital Mammography Equipment standard reports
Currency USD
$4,995

Can be used by individual purchaser only

$14,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Medical Devices
New
Global M&A Deals in H1 2026 - Top Themes by…
$495 | August 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at United States Mammography Equipment Market Outlook to 2033: Full Field Digital Mammography Equipment in real time.

  • Access a live United States Mammography Equipment Market Outlook to 2033: Full Field Digital Mammography Equipment dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.